The expert is a physician specializing in Hematology and Medical Oncology with more than 10 years of experience in the diagnosis and management of complex hematologic disorders and malignancies. Board certified in Internal Medicine, Hematology, and Medical Oncology, the expert’s clinical focus includes myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), anemia, aplastic anemia, bone marrow failure disorders, blood transfusion management, and bone marrow biopsy procedures. Clinical practice also encompasses the treatment of benign hematologic conditions such as cytopenias, as well as the integration of oncology principles in hematologic malignancies.

The expert holds a Doctor of Medicine degree and a Master of Science in Clinical Research. With prior experience providing services as a hematology expert witness, the expert offers litigation support in matters involving hematologic malignancies, bone marrow disorders, clinical trial standards, and oncologic care. This includes case review, consultation, and other expert services consistent with medical-legal evaluation in the field of Hematology and Medical Oncology.

In addition to clinical practice, the expert maintains an active academic and research portfolio centered on early-phase and translational clinical trials in MDS and AML. The expert has served as Principal Investigator and Co-Investigator on multiple phases of clinical trials involving investigational agents and combination therapies for hematologic malignancies. The expert has authored and co-authored peer-reviewed journal articles, textbook chapters, and numerous scientific abstracts, and has presented research findings at national and international hematology conferences. Professional activities also include service on institutional committees such as an Institutional Review Board and protocol review committees, as well as participation in chemotherapy oversight and disease-focused groups.